In MS patients, fatigue and difficulty with walking are 2 of the most common and disabling symptoms. Fatigue is a multidimensional and complex symptom, affecting 70-90% of MS patients. The prevalence of walking impairment increases from 32% to 100% across the adult life span. In the last few decades, exercise has proven to be a promising approach to alleviate fatigue and to improve walking impairment.
Researchers from Denmark investigated the effects of a 24-week high-intensity progressive aerobic exercise intervention, followed by 24 weeks of follow-up, on self-reported fatigue impact and severity, objectively measured walking capacity, self-reported walking ability, and quality of life [1]. A total of 86 mildly to severely impaired MS patients were randomised to exercise or habitual lifestyle, with a 24-week crossover follow-up.
The nominal differences between group were as follows:
- Fatigue impact, measured by the Modified Fatigue Impact Scale (MFIS) total score: Δ -5.3;
- MFIS physical subscore: Δ -2.8;
- MFIS psychosocial subscore: Δ -0.9;
- Walking ability, measured by the 12-item MS Walking Scale (MSWS-12): Δ -5.9;
- Walking capacity, measured by the 6-Minute Walk Test (6MWT): Δ +14 meters; and
- Cardiorespiratory fitness, measured by VO2max: Δ +3.5 mL O2/min/kg.
These improvements were maintained at follow-up after 48 weeks.
No changes were observed in Fatigue Severity Scale (FSS), Six Spot Step Test (SSST), nor in the physical and mental subscores of the Short Form health survey (SF-36).
- Langeskov-Christensen M, et al. Efficacy of aerobic exercise on fatigue, walking, and quality of life in MS. ECF 28th Annual Meeting. Abstract 26.
Posted on
Previous Article
« Reliable and convenient method to assess cognitive function in MS patients Next Article
No increased risk with IFN-β use during pregnancy »
« Reliable and convenient method to assess cognitive function in MS patients Next Article
No increased risk with IFN-β use during pregnancy »
Table of Contents: ECF 2020
Featured articles
ECF Round-Up Articles
No association between Ig levels and infection in ofatumumab-treated patients with relapsing MS
Defining phenotypes of MS-related cognitive impairment
First long-term efficacy data of a BTK inhibitor
Novel disease-specific scale confirms huge impact of fatigue
Progressive aerobic exercise improves fatigue
Reliable and convenient method to assess cognitive function in MS patients
Tackling unmet MS-related cognitive challenges
Real-world efficacy of ocrelizumab in MS patients
Similar demographics, clinical characteristics, and treatment patterns in German claims study
Decreased EDSS after plasma exchange in NMOSD
No support for IVIG as treatment of acute attacks in NMOSD
Related Articles
December 16, 2020
Tackling unmet MS-related cognitive challenges
December 16, 2020
Progressive aerobic exercise improves fatigue
December 16, 2020
Novel disease-specific scale confirms huge impact of fatigue
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com